| Source HCPCS Code |
|
Target NDC Code |
Q5133
Injection, tocilizumab-bavi (tofidence), biosimilar, 1 mg
|
⇄
|
64406-0022-01
TOFIDENCE 200 MG/10 ML VIAL
|
| Detail Information |
| Relationship Start Date |
10/01/2024 |
| Relationship End Date |
12/31/3999 |
| Number Of Items In Ndc Package |
10 |
| Ndc Package Measure |
ML |
| Ndc Package Type |
VIAL |
| Route Of Administration |
IV |
| Billing Units |
ML |
|
|
|
Q5133
Injection, tocilizumab-bavi (tofidence), biosimilar, 1 mg
|
⇄
|
64406-0023-01
TOFIDENCE 400 MG/20 ML VIAL
|
| Detail Information |
| Relationship Start Date |
10/01/2024 |
| Relationship End Date |
12/31/3999 |
| Number Of Items In Ndc Package |
20 |
| Ndc Package Measure |
ML |
| Ndc Package Type |
VIAL |
| Route Of Administration |
IV |
| Billing Units |
ML |
|
|
|
Q5133
Injection, tocilizumab-bavi (tofidence), biosimilar, 1 mg
|
⇄
|
64406-0024-01
TOFIDENCE 80 MG/4 ML VIAL
|
| Detail Information |
| Relationship Start Date |
10/01/2024 |
| Relationship End Date |
12/31/3999 |
| Number Of Items In Ndc Package |
4 |
| Ndc Package Measure |
ML |
| Ndc Package Type |
VIAL |
| Route Of Administration |
IV |
| Billing Units |
ML |
|
|
|
Q5133
Inj, tofidence, 1 mg
|
⇄
|
64406-0022-01
Tofidence
|
| Detail Information |
| Relationship Start Date |
|
| Relationship End Date |
|
| Number Of Items In Ndc Package |
|
| Ndc Package Measure |
|
| Ndc Package Type |
|
| Route Of Administration |
|
| Billing Units |
|
|
|
|
Q5133
Inj, tofidence, 1 mg
|
⇄
|
64406-0023-01
Tofidence
|
| Detail Information |
| Relationship Start Date |
|
| Relationship End Date |
|
| Number Of Items In Ndc Package |
|
| Ndc Package Measure |
|
| Ndc Package Type |
|
| Route Of Administration |
|
| Billing Units |
|
|
|
|
Q5133
Inj, tofidence, 1 mg
|
⇄
|
64406-0024-01
Tofidence
|
| Detail Information |
| Relationship Start Date |
|
| Relationship End Date |
|
| Number Of Items In Ndc Package |
|
| Ndc Package Measure |
|
| Ndc Package Type |
|
| Route Of Administration |
|
| Billing Units |
|
|
|
|